Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image remdesivir

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California. On 8 October, the company inked an agreement to supply the European Union with its drug remdesivir as a treatment for COVID-19—a deal potentially worth more than $1 billion. Two weeks later, on 22 October, the U.S. Food and Drug Administration (FDA) approved remdesivir for use against the pandemic coronavirus SARS-CoV-2 in the United States—the first drug to receive that status. The EU and U.S. decisions pave the way for Gilead’s drug into two major markets, both with soaring COVID-19 cases.

Read the full article here

By Malvika|2020-10-30T16:52:07+00:00October 30th, 2020|News-Articles|Comments Off on The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Malvika

Avatar

Related Posts

  • Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Gallery

    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official

  • Study suggests Pfizer vaccine works against virus variant
    Study suggests Pfizer vaccine works against virus variant
    Gallery

    Study suggests Pfizer vaccine works against virus variant

  • Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Gallery

    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says

  • First shipments of Pfizer vaccine to be delivered December 15
    First shipments of Pfizer vaccine to be delivered December 15
    Gallery

    First shipments of Pfizer vaccine to be delivered December 15

  • Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Gallery

    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area